Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 19, Pages 4854
Publisher
MDPI AG
Online
2021-09-29
DOI
10.3390/cancers13194854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption
- (2021) Navid Sobhani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Osteopontin accelerates the development and metastasis of bladder cancer via activating JAK1/STAT1 pathway
- (2020) Na Zhang et al. Genes & Genomics
- TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway
- (2020) Hongwen Cao et al. FEBS Open Bio
- Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC
- (2020) Kelvin Anderson et al. Frontiers in Immunology
- Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
- (2020) Wook Jin Cells
- Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer
- (2020) Konrad H. Stopsack et al. CLINICAL CANCER RESEARCH
- Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics
- (2020) Bastien Nguyen et al. EUROPEAN UROLOGY
- Microbiome analyses of blood and tissues suggest cancer diagnostic approach
- (2020) Gregory D. Poore et al. NATURE
- Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
- (2020) Holger H. H. Erb et al. PLoS One
- STAT3 Contributes to Radioresistance in Cancer
- (2020) Xuehai Wang et al. Frontiers in Oncology
- STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
- (2020) Giacomo Canesin et al. Scientific Reports
- Endothelial-to-Mesenchymal Transition in Cancer
- (2020) Nicolas Clere et al. Frontiers in Cell and Developmental Biology
- JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
- (2019) Soheila Dolatabadi et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
- (2019) Wenjuan Mei et al. Cancers
- MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling
- (2019) Lei Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer‐bone microenvironmental interactions promotes STAT3 signaling
- (2019) Veronica M. Henderson et al. MOLECULAR CARCINOGENESIS
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Upregulation of Complement Factor H by SOCS-1/3–STAT4 in Lung Cancer
- (2019) Yeon-Hee Yoon et al. Cancers
- STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice
- (2019) Boutillon et al. Cancers
- Enzalutamide Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors
- (2019) Vindhya Udhane et al. MOLECULAR CANCER THERAPEUTICS
- STAT1 inhibits T‐cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma
- (2019) Nathan Ryan et al. INTERNATIONAL JOURNAL OF CANCER
- A NF-ĸB-Activin A signaling axis enhances prostate cancer metastasis
- (2019) Lanpeng Chen et al. ONCOGENE
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
- (2019) Katie L. Owen et al. Cancers
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy
- (2018) Alison M. Taylor et al. CANCER CELL
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
- (2018) Li Ding et al. CELL
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
- (2018) Katherine A. Hoadley et al. CELL
- STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
- (2018) Cristina Maranto et al. CLINICAL CANCER RESEARCH
- Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
- (2018) Shancheng Ren et al. EUROPEAN UROLOGY
- Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
- (2018) Jun Luo et al. EUROPEAN UROLOGY
- Profiling Prostate Cancer Therapeutic Resistance
- (2018) Cameron Wade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer
- (2018) Lan Zhang et al. Molecular Medicine Reports
- Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
- (2018) LiJun Xu et al. Molecular Oncology
- The long tail of oncogenic drivers in prostate cancer
- (2018) Joshua Armenia et al. NATURE GENETICS
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
- (2018) Qingsong Gao et al. Cell Reports
- Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
- (2018) Kyle Ellrott et al. Cell Systems
- Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
- (2018) Adam Sharp et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA‑135a induces prostate cancer cell apoptosis via inhibition of STAT6
- (2018) Bin Xu et al. Oncology Letters
- Expression of STAT3 in Prostate Cancer Metastases
- (2017) Nicholas Don-Doncow et al. EUROPEAN UROLOGY
- Genomic hallmarks of localized, non-indolent prostate cancer
- (2017) Michael Fraser et al. NATURE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis
- (2017) L Zhao et al. ONCOGENE
- Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
- (2017) Qiuli Liu et al. Cell Death & Disease
- The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
- (2017) G Nappo et al. Oncogenesis
- Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
- (2017) Andrea Majoros et al. Frontiers in Immunology
- STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade
- (2017) Sanjay Varikuti et al. OncoImmunology
- The molecular and cellular origin of human prostate cancer
- (2016) John R. Packer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The mouse prostate: a basic anatomical and histological guideline
- (2016) Daniel S.M. Oliveira et al. Bosnian Journal of Basic Medical Sciences
- Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
- (2016) Daniela Verzella et al. CURRENT DRUG TARGETS
- The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer
- (2016) Giacomo Canesin et al. EUROPEAN UROLOGY
- STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases
- (2016) Tiziana Lorenzini et al. JOURNAL OF LEUKOCYTE BIOLOGY
- SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells
- (2016) F. Handle et al. MOLECULAR CANCER RESEARCH
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
- (2015) Pooja G. Talati et al. AMERICAN JOURNAL OF PATHOLOGY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease
- (2015) Rukhsana Jabeen et al. INFLAMMATORY BOWEL DISEASES
- Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence
- (2015) Sophia Hatziieremia et al. MOLECULAR CARCINOGENESIS
- Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma
- (2015) Gang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6
- (2015) NING WANG et al. Oncology Letters
- STAT3 regulated ARF expression suppresses prostate cancer metastasis
- (2015) Jan Pencik et al. Nature Communications
- Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
- (2015) Xiaohong Tian et al. Frontiers in Pharmacology
- Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer
- (2015) D. T. Hoang et al. MOLECULAR CANCER THERAPEUTICS
- PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
- (2015) Martin Puhr et al. Oncotarget
- Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer
- (2015) Zhiqiang Han et al. Oncotarget
- Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
- (2015) Jie Yuan et al. Scientific Reports
- Cooperation between Stat3 and Akt Signaling Leads to Prostate Tumor Development in Transgenic Mice
- (2015) Jorge M. Blando et al. NEOPLASIA
- High STAT4 Expression is a Better Prognostic Indicator in Patients with Hepatocellular Carcinoma After Hepatectomy
- (2014) Gizachew Yismaw Wubetu et al. ANNALS OF SURGICAL ONCOLOGY
- MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6)
- (2014) Dachuang Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AR function in promoting metastatic prostate cancer
- (2014) Michael A. Augello et al. CANCER AND METASTASIS REVIEWS
- Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation
- (2014) L. Gu et al. MOLECULAR CANCER THERAPEUTICS
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression
- (2014) R Jin et al. ONCOGENE
- Copy number alteration burden predicts prostate cancer relapse
- (2014) H. Hieronymus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development
- (2014) Elias A. El-Habr et al. VIRCHOWS ARCHIV
- The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
- (2014) Jennifer Bishop et al. Cancers
- STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression
- (2013) Bassem R. Haddad et al. AMERICAN JOURNAL OF PATHOLOGY
- JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
- (2013) P. Kroon et al. CANCER RESEARCH
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
- (2013) M Conley-LaComb et al. Molecular Cancer
- Interleukin-6 and Oncostatin-M Synergize with the PI3K/AKT Pathway to Promote Aggressive Prostate Malignancy in Mouse and Human Tissues
- (2013) Daniel A. Smith et al. MOLECULAR CANCER RESEARCH
- AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
- (2013) E. R. Plimack et al. ONCOLOGIST
- Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone
- (2013) Renjie Jin et al. PLoS One
- Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells
- (2013) T. Stoyanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells
- (2013) Chengfei Liu et al. PROSTATE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
- (2012) Gary Hudes et al. INVESTIGATIONAL NEW DRUGS
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
- (2012) Jordi Codony-Servat et al. PROSTATE
- Detection of STAT2 in early stage of cervical premalignancy and in cervical cancer
- (2012) Zeng Liang et al. Asian Pacific Journal of Tropical Medicine
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo
- (2011) C. Thomas et al. MOLECULAR CANCER THERAPEUTICS
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- New and emerging agents for the treatment of castration-resistant prostate cancer
- (2011) Celestia S. Higano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Signal Transducer and Activator of Transcription 6 (STAT6) Is a Novel Interactor of Annexin A2 in Prostate Cancer Cells
- (2010) Susobhan Das et al. BIOCHEMISTRY
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- STAT2 Contributes to Promotion of Colorectal and Skin Carcinogenesis
- (2010) A. M. Gamero et al. Cancer Prevention Research
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
- (2010) Lei Gu et al. ENDOCRINE-RELATED CANCER
- Induction of Clusterin by AKT--Role in Cytoprotection against Docetaxel in Prostate Tumor Cells
- (2010) B. Zhong et al. MOLECULAR CANCER THERAPEUTICS
- Protein kinase Cɛ mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2 and ERK1/2)
- (2010) M H Aziz et al. ONCOGENE
- Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency
- (2009) Hsiang-Yuan Yeh et al. BMC Medical Genomics
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells
- (2008) S.-H. Tan et al. CANCER RESEARCH
- The Nuclear Factor- B Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth
- (2008) R. J. Jin et al. CANCER RESEARCH
- Transcription Factor Signal Transducer and Activator of Transcription 5 Promotes Growth of Human Prostate Cancer Cells In vivo
- (2008) A. Dagvadorj et al. CLINICAL CANCER RESEARCH
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
- (2008) Marina Zemskova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
- (2008) Richard Birnie et al. GENOME BIOLOGY
- Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
- (2007) Rebecka Hellsten et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search